CHATSWORTH, Calif., March 1, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), reflecting improved instruments sales and record sales of consumables and service, today announced revenue of $26.5 million for the fourth quarter ended December 31, 2009, relatively flat from revenue of $26.7 in the prior year fourth quarter. Net income in the 2009 fourth quarter of $1.9 million, or $0.11 per diluted share, which included a one-time accrual of $0.5 million, or $0.02 per diluted share, for payroll taxes attributable to the exercise of stock options, compares with net income of $3.4 million, or $0.18 per diluted share, in the year ago period, which included a one-time gain of $1.2 million, or $0.04 per diluted share, related to the manufacturing transition and licensing agreement signed with IDEXX Laboratories in December 2008. Diluted weighted average shares outstanding for the three months ended December 31, 2009 and 2008, were 18.0 million and 18.5 million, respectively.
